This paper is in the following e-collection/theme issue:

Mass Media/Social Media Communication and Campaigns (446) Medicine 2.0: Social Media, Open, Participatory, Collaborative Medicine (1552) Infodemiology and Infoveillance (1269) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (143) Safety and Error Prevention in Health (186) Infoveillance, Infodemiology, Digital Disease Surveillance, Infodemic Management (1010)

Published on in Vol 4, No 1 (2018): Jan-Mar

Social Media Impact of the Food and Drug Administration's Drug Safety Communication Messaging About Zolpidem: Mixed-Methods Analysis

Social Media Impact of the Food and Drug Administration's Drug Safety Communication Messaging About Zolpidem: Mixed-Methods Analysis

Social Media Impact of the Food and Drug Administration's Drug Safety Communication Messaging About Zolpidem: Mixed-Methods Analysis

Authors of this article:

Michael S Sinha1 Author Orcid Image ;   Clark C Freifeld2 Author Orcid Image ;   John S Brownstein3 Author Orcid Image ;   Macarius M Donneyong4 Author Orcid Image ;   Paula Rausch5 Author Orcid Image ;   Brian M Lappin5 Author Orcid Image ;   Esther H Zhou5 Author Orcid Image ;   Gerald J Dal Pan5 Author Orcid Image ;   Ajinkya M Pawar1 Author Orcid Image ;   Thomas J Hwang1 Author Orcid Image ;   Jerry Avorn1 Author Orcid Image ;   Aaron S Kesselheim1 Author Orcid Image
Article Authors Cited by (22) Tweetations (55) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.